IL1A and periodontitis: Conversely, testosterone therapy in transgender males increases pro-inflammatory cytokines (e.g., TNF-α, IL-1α, CXCL1) and Th17 cells, potentially heightening inflammation in periodontal tissues and elevating periodontitis risk.